Luiz Claudio Navarro

Luiz Claudio Navarro

Auto-generated profile, based on publicly available information

Luiz Claudio Navarro

RECOD Laboratory, Institute of Computing, University of Campinas, Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Forensic Science International
Verified
Journal Article
Closed access
AFAnselmo Ferreira
Anselmo Ferreira
LNLuiz C. Navarro
Luiz C. Navarro
GPGiuliano Pinheiro
Giuliano Pinheiro
JSJefersson A. dos Santos
Jefersson A. dos Santos
ARAnderson Rocha
Anderson Rocha

11 April 2018 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
CMCarlos Fernando Odir Rodrigues Melo
Carlos Fernando Odir Rodrigues Melo
LNLuiz Claudio Navarro
Luiz Claudio Navarro
DODiogo Noin de Oliveira
Diogo Noin de Oliveira
TGTatiane Melina Guerreiro
Tatiane Melina Guerreiro
ELEstela de Oliveira Lima
Estela de Oliveira Lima
RCRodrigo Catharino
Rodrigo Catharino
Recent Zika outbreaks in South America, accompanied by unexpectedly severe clinical complications have brought much interest in fast and reliable screening methods for ZIKV (Zika virus) identification. Reverse-transcriptase polymerase chain reaction (RT-PCR) is currently the method of choice to detect ZIKV in biological samples. This approach, nonetheless, demands a considerable amount of time and resources such as kits and reagents that, in endemic areas, may result in a substantial financial burden over affected individuals and health services veering away from RT-PCR analysis. This study presents a powerful combination of high-resolution mass spectrometry and a machine-learning prediction model for data analysis to assess the existence of ZIKV infection across a series of patients that bear similar symptomatic conditions, but not necessarily are infected with the disease. By using mass spectrometric data that are inputted with the developed decision-making algorithm, we were able to provide a set of features that work as a “fingerprint” for this specific pathophysiological condition, even after the acute phase of infection. Since both mass spectrometry and machine learning approaches are well-established and have largely utilized tools within their respective fields, this combination of methods emerges as a distinct alternative for clinical applications, providing a diagnostic screening—faster and more accurate—with improved cost-effectiveness when compared to existing technologies.

1 September 2018 in Computers & Security
Verified
Journal Article
Closed access
LNLuiz C. Navarro
Luiz C. Navarro
ANAlexandre K.W. Navarro
Alexandre K.W. Navarro
AGAndré Grégio
André Grégio
ARAnderson Rocha
Anderson Rocha
RDRicardo Dahab
Ricardo Dahab

1 May 2018 in Journal of Visual Communication and Image Representation
Verified
Journal Article
Closed access
LNLuiz C. Navarro
Luiz C. Navarro
ANAlexandre K.W. Navarro
Alexandre K.W. Navarro
ARAnderson Rocha
Anderson Rocha
RDRicardo Dahab
Ricardo Dahab

30 June 2020 in mSystems
Verified
Journal Article
Open access
PDF file
ELEstela de Oliveira Lima
Estela de Oliveira Lima
LNLuiz Claudio Navarro
Luiz Claudio Navarro
KMKaren Noda Morishita
Karen Noda Morishita
CKCamila Mika Kamikawa
Camila Mika Kamikawa
RRRafael Gustavo Martins Rodrigues
Rafael Gustavo Martins Rodrigues
RCRodrigo Catharino
Rodrigo Catharino
Paracoccidioidomycosis (PCM) is a fungal infection typically found in Latin American countries, especially in Brazil. The identification of this disease is based on techniques that may fail sometimes. Intending to improve PCM detection in patient samples, this study used the combination of two of the newest technologies, artificial intelligence and metabolomics. This combination allowed PCM detection, independently of disease form, through identification of a set of molecules present in patients’ blood. The great difference in this research was the ability to detect disease with better confidence than the routine methods employed today. Another important point is that among the molecules, it was possible to identify some indicators of contamination and other infection that might worsen patients’ condition. Thus, the present work shows a great potential to improve PCM diagnosis and even disease management, considering the possibility to identify concomitant harmful factors.

22 June 2015
Verified
Conference Paper
Open access
RGRoberto Gallo
Roberto Gallo
PHPatricia Hongo
Patricia Hongo
RDRicardo Dahab
Ricardo Dahab
LNLuiz C. Navarro
Luiz C. Navarro
HKHenrique Kawakami
Henrique Kawakami
LRLuander Ribeiro
Luander Ribeiro